Article Title,Year,Volume,Issue,Page Range,Author
A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety suicide and mortality due to antidepressant overdose,2013,3,3,151-161,Taylor
An evaluation of the use of olanzapine pamoate depot injection in seriously violent men with schizophrenia in a UK high-security hospital,2014,4,5,186-192,Young
Legal highs: staying on top of the flood of novel psychoactive substances,2015,5,2,97-132,Tracy
Improvement of nonsuicidal self-injury following treatment with antipsychotics possessing strong D1 antagonistic activity: evidence from a report of three cases,2015,5,4,208-213,Schmidt
Evaluation of olanzapine pamoate depot in seriously violent males with schizophrenia in the community,2016,6,5,301-307,Kasinathan
Effectiveness of paliperidone depot injection in seriously violent men with comorbid schizophrenia and dissocial personality disorder in a UK high-security hospital,2017,7,5,169-179,Gupta
Frontotemporal dementia: latest evidence and clinical implications,2018,8,1,33-48,Tampi
Suicidal and non-suicidal self-injurious behaviour in patients with bipolar disorder and comorbid attention deficit hyperactivity disorder after initiation of central stimulant treatment: a mirror-image study based on the LiSIE retrospective cohort,2020,10,,e2045125320947502,Ott
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products,2020,10,,e2045125320954992,McGuire
The effect of monoamine oxidase-B inhibitors on the alleviation of depressive symptoms in Parkinson's disease: meta-analysis of randomized controlled trials,2021,11,,e2045125320985993,Huang
Excess deaths in treatment-resistant depression,2021,11,,e20451253211006508,Reutfors
The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes,2022,12,,e20451253221097452,Cahn
Synthetic opioids: a review and clinical update,2022,12,,e20451253221139616,Wood
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review,2023,13,,e20451253231151327,Jollant
Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report,2017,7,3,113-117,Kikuchi
Urgent release of severe psychomotor retardation with intramuscular lorazepam: a case report,2017,7,10,227-229,Kanzawa
A study of the efficacy and safety of switching from oral risperidone to risperidone long-acting injection in older patients with schizophrenia,2012,2,6,227-234,Inoue
Long-term remission in schizophrenia and schizoaffective disorder: Results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE),2013,3,4,191-199,Folnegovic-Smalc
Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence a systematic literature review,2013,3,4,200-218,De Hert
Adjuvant valproate therapy for patients with suspected mixed-depressive features,2014,4,4,143-148,Liu
Clozapine prescribing in the UK: Views and experience of consultant psychiatrists,2015,5,2,88-96,Farooq
Use of automated medication adherence monitoring in bipolar disorder research: Pitfalls pragmatics and possibilities,2015,5,2,76-87,Levin
Medication nonadherence in bipolar disorder: a narrative review,2018,8,12,349-363,Watson
Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England,2020,10,,,Davies
Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Disorder,2020,10,,,Marwaha
Resolution without discontinuation: heart failure during clozapine treatment,2020,10,,,Taylor
Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression,2021,11,,,Cubała
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA,2021,11,,,Plöderl
Experiences with benzodiazepine use tapering and discontinuation: an Internet survey,2022,12,,,Reid Finlayson
Physical health monitoring after rapid tranquillisation: clinical practice in UK mental health services,2019,9,,e2045125319895839,Adams
Clinical characteristics and unlicensed applications of licensed psychotropic drugs within a regional tertiary service for patients with affective disorders,2020,10,,e2045125318795132,Baldwin
A 6-week phase IIb randomized double-blind placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults,2023,13,,,Ding
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia,2023,13,,,Wong
Ketamine for bipolar depression: an updated systematic review,2023,13,,e20451253231202723,Mansur
Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery,2024,14,,e20451253241264812,Garcia-Barrera